Grace Therapeutics, Inc. (GRCE)
Stock-Based Compensation
$395.00K
TTM · Period ending: · USD
GRCE Stock-Based Compensation
Latest reported$395.00Kperiod ending
Latest reported$395.00Kperiod ending
GRCE TTM Stock-Based Comp ($56.62K → $395.00K)
TTM stock-based compensation
High-resolution chart · PNG
GRCE stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 395,000 | |
| 592,000 | |
| 746,000 | |
| 592,000 | |
| 794,000 | |
| 730,000 | |
| 829,000 | |
| 995,000 | |
| 1,073,000 | |
| 913,000 | |
| 1,006,000 | |
| 1,123,000 | |
| 1,425,000 | |
| 1,811,000 | |
| 2,105,000 | |
| 2,116,000 | |
| 1,648,000 | |
| 1,373,221 | |
| 972,039 | |
| 479,733 | |
| 899,305 | |
| 1,567,237 | |
| 1,697,780 | |
| 2,347,086 | |
| 2,463,514 | |
| 1,856,361 | |
| 1,620,335 | |
| 1,256,025 | |
| 858,345 | |
| 799,190 | |
| 883,577 | |
| 899,312 | |
| 884,793 | |
| 721,628 | |
| 643,272 | |
| 541,266 | |
| 353,301 | |
| 403,014 | |
| 320,525 | |
| 221,600 | |
| 232,621 | |
| 178,005 | |
| 390,439 | |
| 716,467 | |
| 1,295,020 | |
| 1,913,264 | |
| 2,675,102 | |
| 3,229,777 | |
| 3,115,195 | |
| 2,872,774 | |
| 2,280,083 | |
| 1,864,553 | |
| 1,853,686 | |
| 2,007,003 | |
| 1,935,255 | |
| 1,714,150 | |
| 1,351,996 | |
| 845,391 | |
| 559,296 | |
| 253,734 | |
| 101,927 | |
| 56,615 | |
| 0 | |
| 0 | |
| 0 |